Clinical Trial Detail

NCT ID NCT01776307
Title A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Boston Biomedical, Inc
Indications

colorectal cancer

Therapies

Cetuximab + Napabucasin

Capecitabine + Napabucasin

Napabucasin + Panitumumab

Age Groups: adult

Additional content available in CKB BOOST